Suchbegriffe: PLATELET FUNCTION TESTS - METHODS , . Treffer: 8
Enko, D; Mangge, H; Münch, A; Niedrist, T; Mahla, E; Metzler, H; Prüller, F
Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.
Biochem Med (Zagreb). 2017; 27(1):217-224
Doi: 10.11613/BM.2017.023
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Prüller, F; Rosskopf, K; Mangge, H; Mahla, E; von Lewinski, D; Weiss, EC; Riegler, A; Enko, D
Implementation of buffy-coat-derived pooled platelet concentrates for internal quality control of light transmission aggregometry: a proof of concept study.
J Thromb Haemost. 2017; 15(12):2443-2450
Doi: 10.1111/jth.13870
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mahla, E; Raggam, R; Toller, W
Platelet function testing to time surgery in patients on dual antiplatelet therapy?
Hamostaseologie. 2014; 34(1):40-45
Doi: 10.5482/HAMO-13-06-0032
Web of Science
PubMed
FullText
FullText_MUG
Robier, C; Neubauer, M; Quehenberger, F; Stettin, M; Neumeister, P
Assessment of the response to acetylsalicylic acid in patients with myeloproliferative neoplasms by whole blood assays: a comparison of the PFA-100 with multiple electrode aggregometry.
Platelets. 2014; 25(8):608-611
Doi: 10.3109/09537104.2013.852661
Web of Science
PubMed
FullText
FullText_MUG
Metzler, H; Prüller, F; Münch, A; Primus, G; Kainz, J; Hödl, R; Rehak, P
Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.
Eur J Anaesthesiol. 2010; 27(2):138-145
Doi: 10.1097/EJA.0b013e32832eb521
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Mahla, E; Antonino, MJ; Tantry, US; Gurbel, PA
Point-of-care platelet function analysis ready for prime time?
J Am Coll Cardiol. 2009; 53(10): 857-859.
Doi: 10.1016/j.jacc.2008.11.033
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
von Lewinski, F; Riggert, J; Paulus, W
Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
J Stroke Cerebrovasc Dis. 2009; 18(2):111-115
Doi: 10.1016/j.jstrokecerebrovasdis.2008.09.010
Web of Science
PubMed
FullText
FullText_MUG
Fitscha, P; Kaliman, J; Sinzinger, H; Peskar, BA
Follow-up of in-vivo platelet function (platelet half-life, thromboxane B2) in patients with coronary heart disease.
Vasa. 1984; 13(4):338-342
Web of Science
PubMed
Google Scholar